Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257.HK) announced that on October 29, 2026, the company granted approximately 893,600 share options to 25 share option grantees and approximately 2,048,800 restricted share units to 27 restricted share unit grantees (excluding Dr. Pan Honghui) in accordance with the terms of the 2026 share option plan and the 2026 restricted share unit plan, and conditionally granted 1 million restricted share units to Dr. Pan Honghui, subject to the restricted share option grantor and beneficiaries Shareholder It came true after Dr. Pan accepted it.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.